Bedfont Scientific Limited

Bedfont has seen a high demand for its NObreath® FeNO monitor following Rapid Uptake Products (RUP) programme

Local company, Bedfont Scientific Ltd., fundraises and skydives to raise money for the Heart of Kent Hospice

Bedfont presents its new Hydrogen and Methane Breath Testing Home Kits in association with GI Cognition

NHS Organisations can apply for funding from the Pathway Transformation Fund (PTF) to obtain a NObreath® used for asthma diagnosis and management.

Smoking in Pregnancy Midwife, Faye Ballard, joins Bedfont's Medical Advisory Board for No Smoking Day 2021

Bedfont's breath analysis medical device for helping to detect GI disorders can now be sold in the UAE

The new Bluetooth® CO monitor from Bedfont® Scientific Ltd. has helped Stop Smoking Clinics to continue giving essential advice to its patients through remote CO monitoring

Bedfont hosts a virtual launch party to officiate the opening of Bedfont GmbH

Medical device manufacturer launches new incentive spirometer, Breathacise®

The NObreath Fractional exhaled Nitric Oxide (FeNO) monitor from Bedfont is being used in a novel study to see if FeNO levels are affected by COVID-19